Drug network identification predicts injecting risk behavior among people who inject drugs on hepatitis C virus treatment in Tayside, Scotland
暂无分享,去创建一个
F. Sani | J. Dillon | A. Eriksen | C. Byrne | Amy Malaguti | Kevin Power
[1] C. Treloar,et al. Peer-facilitated treatment access for hepatitis C: the Live Hep C Free project , 2022, Harm Reduction Journal.
[2] S. Hutchinson,et al. Real‐world outcomes of rapid regional hepatitis C virus treatment scale‐up among people who inject drugs in Tayside, Scotland , 2021, Alimentary pharmacology & therapeutics.
[3] P. Hayes,et al. Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs , 2021, Journal of hepatology.
[4] E. Cama,et al. Positive effects of community attachment on internalised stigma and wellbeing among people who inject drugs. , 2021, The International journal on drug policy.
[5] H. E. Ahmad,et al. Assessment of anxiety and depression among substance use disorder patients: a case-control study , 2020, Middle East Current Psychiatry.
[6] C. Strike,et al. 'It's too much, I'm getting really tired of it': Overdose response and structural vulnerabilities among harm reduction workers in community settings. , 2019, The International journal on drug policy.
[7] N. Luhmann,et al. We know DAAs work, so now what? Simplifying models of care to enhance the hepatitis C cascade , 2019, Journal of internal medicine.
[8] L. Brener,et al. Care, agency and criminality: Making sense of authorised extended distribution in the accounts of key stakeholders. , 2019, The International journal on drug policy.
[9] F. Sani,et al. Change in injecting behaviour among people treated for hepatitis C virus: The role of intimate partnerships , 2018, Journal of viral hepatitis.
[10] J. Leung,et al. Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs , 2018, Addiction.
[11] G. Dingle,et al. The New Psychology of Health: Unlocking the Social Cure , 2018, Clinical Psychology Forum.
[12] Atte Oksanen,et al. Addictive behaviors and psychological distress among adolescents and emerging adults: A mediating role of peer group identification , 2018, Addictive behaviors reports.
[13] C. Latkin,et al. Understanding and addressing hepatitis C reinfection in the oral direct‐acting antiviral era , 2018, Journal of viral hepatitis.
[14] Mark S. Edwards,et al. Illness Perceptions, Coping, Benefit Finding, and Adjustment in Individuals with Hepatitis C , 2018 .
[15] C. Treloar,et al. Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting. , 2018, Drug and alcohol dependence.
[16] C. von Hippel,et al. Implicit and explicit internalized stigma: Relationship with risky behaviors, psychosocial functioning and healthcare access among people who inject drugs. , 2018, Addictive behaviors.
[17] Mark S. Edwards,et al. The Self-Regulatory Model of Illness and Adjustment Outcomes in Hepatitis C , 2017 .
[18] S. Fraser,et al. "Don't think I'm going to leave you over it": Accounts of changing hepatitis C status among couples who inject drugs. , 2017, Drug and alcohol dependence.
[19] S. Fraser,et al. Hepatitis C prevention and convenience: why do people who inject drugs in sexual partnerships ‘run out’ of sterile equipment? , 2016 .
[20] Michael A. Jenkins-Guarnieri,et al. The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5): Development and Evaluation Within a Veteran Primary Care Sample , 2016, Journal of General Internal Medicine.
[21] P. Pattison,et al. Hepatitis C transmission and treatment as prevention - The role of the injecting network. , 2015, The International journal on drug policy.
[22] F. Sani,et al. Greater number of group identifications is associated with healthier behaviour: Evidence from a Scottish community sample. , 2015, British journal of health psychology.
[23] F. Sani,et al. Greater number of group identifications is associated with lower odds of being depressed: evidence from a Scottish community sample , 2015, Social Psychiatry and Psychiatric Epidemiology.
[24] G. E. Harris,et al. Peering into the literature: A systematic review of the roles of people who inject drugs in harm reduction initiatives. , 2015, Drug and alcohol dependence.
[25] C. Shapiro,et al. The importance of fatigue cognitions in chronic hepatitis C infection. , 2015, Journal of psychosomatic research.
[26] M. Newman,et al. Delay discounting and the use of mindful attention versus distraction in the treatment of drug addiction: a conceptual review. , 2015, Journal of the experimental analysis of behavior.
[27] P. Pattison,et al. The impact of injecting networks on hepatitis C transmission and treatment in people who inject drugs , 2014, Hepatology.
[28] G. Donenberg,et al. Psychiatric correlates of injection risk behavior among young people who inject drugs. , 2014, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors.
[29] G. Dingle,et al. Depression and Social Identity , 2014, Personality and social psychology review : an official journal of the Society for Personality and Social Psychology, Inc.
[30] P. Sedgwick. Cross sectional studies: advantages and disadvantages , 2014, BMJ : British Medical Journal.
[31] R. Heimer,et al. Associations Between Injection Risk and Community Disadvantage Among Suburban Injection Drug Users in Southwestern Connecticut, USA , 2014, AIDS and Behavior.
[32] T. Rhodes,et al. Hepatitis C Avoidance in Injection Drug Users: A Typology of Possible Protective Practices , 2013, PloS one.
[33] M. Cano,et al. Injecting transition risk and depression among Mexican American non-injecting heroin users. , 2012, Drug and alcohol dependence.
[34] E. Wood,et al. The Injection Support Team: A Peer-Driven Program to Address Unsafe Injecting in a Canadian Setting , 2012, Substance use & misuse.
[35] E. Robles,et al. Delay discounting, impulsiveness, and addiction severity in opioid-dependent patients. , 2011, Journal of substance abuse treatment.
[36] C. Latkin,et al. The relationship between social network factors, HIV, and Hepatitis C among injection drug users in Chennai, India. , 2011, Drug and alcohol dependence.
[37] R. Bruno,et al. Transition to and from injecting drug use among regular ecstasy users. , 2010, Addictive behaviors.
[38] L. Palinkas,et al. The perceived consequences of safer injection: An exploration of qualitative findings and gender differences , 2010, Psychology, health & medicine.
[39] E. Wood,et al. Social structural factors that shape assisted injecting practices among injection drug users in Vancouver, Canada: a qualitative study , 2010, Harm reduction journal.
[40] L. Ouellet,et al. Prevalence and Correlates of Former Injection Drug Use Among Young Noninjecting Heroin Users in Chicago , 2010, Substance use & misuse.
[41] Sudirman Nasir,et al. The social context of initiation into injecting drugs in the slums of Makassar, Indonesia. , 2009, The International journal on drug policy.
[42] M. Bloor,et al. Theorising equipment-sharing in a cohort of Scottish drug users , 2008 .
[43] R. Garfein,et al. Perceived risk, peer influences, and injection partner type predict receptive syringe sharing among young adult injection drug users in five U.S. cities. , 2007, Drug and alcohol dependence.
[44] J. Wylie,et al. Determinants of injection drug user (IDU) syringe sharing: the relationship between availability of syringes and risk network member characteristics in Winnipeg, Canada. , 2007, Addiction.
[45] R. Platt,et al. Social Network-Related Risk Factors for Bloodborne Virus Infections Among Injection Drug Users Receiving Syringes through Secondary Exchange , 2007, Journal of Urban Health.
[46] J. Hyde,et al. Needle-sharing among young IV drug users and their social network members: The influence of the injection partner's characteristics on HIV risk behavior. , 2006, Addictive behaviors.
[47] Elizabeth Broadbent,et al. The brief illness perception questionnaire. , 2006, Journal of psychosomatic research.
[48] B. Löwe,et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. , 2006, Archives of internal medicine.
[49] Don C Des Jarlais,et al. Transitions to Injecting Drug Use Among Noninjecting Heroin Users: Social Network Influence and Individual Susceptibility , 2006, Journal of acquired immune deficiency syndromes.
[50] J. Marsden,et al. Reduced injection risk and sexual risk behaviours after drug misuse treatment: Results from the National Treatment Outcome Research Study , 2002, AIDS care.
[51] R. Spitzer,et al. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. , 1999, JAMA.
[52] G. Stimson,et al. A short questionnaire (IRQ) to assess injecting risk behaviour. , 1998, Addiction.
[53] J. Fountain,et al. Continuing drug risk behaviour: shared use of injecting paraphernalia among London heroin injectors. , 1997, AIDS care.